Cardiovascular companies develop diagnostics, therapies and research technologies for diseases affecting the heart and circulatory system. Their work supports earlier detection, improved disease management and the development of new treatments for cardiovascular conditions.
This category includes companies working on:
Browse 59 UK cardiovascular companies below.
Pre-clinical platelet function testing for drug discovery and safety
Platelet Services is a contract research organisation specialising in pre-clinical platelet function testing for pharmaceutical and biotechnology clients. The company provides…
Nonclinical safety toxicology and ion channel screening services
ApconiX is a nonclinical safety consultancy and ion channel laboratory supporting drug discovery and development programmes. The company provides project toxicology, DMPK support,…
Global biopharma with UK R&D centre on the Wirral Peninsula
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company with a long-established UK R&D site at Moreton on the Wirral Peninsula and its UK and Ireland commercial…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic…
AI echocardiography platform for heart failure detection
Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions. Its cloud-based…
Small molecule drug discovery focused on fibrosis and oncology
Redx Pharma is a clinical-stage biotech developing novel small molecule therapeutics for fibrotic disease and cancer. Its pipeline is anchored by zelasudil, a selective ROCK2…
AI-driven microRNA biomarker diagnostics for early veterinary disease detection
MI:RNA Diagnostics is a UK-based developer of a diagnostic platform combining microRNA biomarker panels with a proprietary artificial intelligence model to detect early-stage…
siRNA therapeutics targeting liver-expressed disease genes
Silence Therapeutics is a clinical-stage biotechnology company developing siRNA therapeutics using its proprietary platform. The platform enables precise silencing of…
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using…
Stem cell-derived exosome platform for targeted drug delivery
ReNeuron is a biotechnology company developing a stem cell-derived exosome platform for targeted therapeutic delivery. Founded on over two decades of stem cell science, including…
Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy
Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead…
Microscopy and imaging systems for developmental and cardiovascular research
Indigo Scientific is a UK manufacturer and supplier of optical and microscopy imaging systems for life science research. The company's High-Resolution Episcopic Microscopy systems…